Virtual Education Program for Atrial Fibrillation

Recruiting at 2 trial locations

Overseen By Tiffany Armbruster, AGNP

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of North Carolina, Chapel Hill

Disqualifiers: Unable to consent, Incarcerated

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

300 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this study is to determine the effectiveness of a direct-to-patient virtual education program ("AF at Home") for adults with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants in the educational program have improvement in quality of life, self-monitoring, and self-management strategies after program completion? 2. Will patient level quality of AF care improve for participants in the educational program? Participants will be asked to: * Participate in six hours of virtual education sessions over three weeks via Zoom. * Complete online questionnaires before the program starts and after its completion.

Research Team

Anil Gehi, MD

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for adults with atrial fibrillation, either non-valvular or valvular. Participants must be 18 years or older and capable of giving informed consent. It's not open to individuals who are incarcerated.

Inclusion Criteria

I have been diagnosed with atrial fibrillation not caused by heart valve issues.

I am 18 years old or older.

Exclusion Criteria

I am unable to understand and agree to the study's details on my own.

Incarcerated patient

Treatment Details

Interventions

• AF at Home

Trial Overview The 'AF at Home' program is being tested to see if it improves quality of life and self-care in people with atrial fibrillation. Participants will attend six hours of virtual education over three weeks and complete questionnaires before and after the program.

Participant Groups

Group I: AF at Home Experimental Treatment 1 Intervention

All recruited participants will participate in the AF at Home educational intervention.

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials

1,588

Recruited

4,364,000+

Bristol-Myers Squibb Foundation

Collaborator

Trials

6

Recruited

1,300+

Bristol-Myers Squibb

Industry Sponsor

Trials

2,731

Recruited

4,127,000+

Headquarters

New York City, USA

Known For

Oncology & Cardiovascular

Top Products

Eliquis, Opdivo, Revlimid, Orencia

Christopher Boerner

Bristol-Myers Squibb

Chief Executive Officer since 2023

PhD in Business Administration from the Haas School of Business, University of California, Berkeley; BA in Economics and History from Washington University in St. Louis

Deepak L. Bhatt

Bristol-Myers Squibb

Chief Medical Officer since 2024

MD from Yale University; MSc in Clinical Epidemiology from the University of Pennsylvania

Wake Forest University

Collaborator

Trials

193

Recruited

151,000+

Duke University

Collaborator

Trials

2,495

Recruited

5,912,000+